Repligen reported $66.75M in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Align Technology ALGN:US $ 222.5M 31.08M
Biomarin Pharmaceutical BMRN:US $ 26.19M 92.76M
Bristol Myers Squibb BMY:US $ 5386M 595M
Bruker BRKR:US $ 111.6M 26.3M
Catalent CTLT:US $ 251M 37M
Danaher DHR:US $ 2561.71M 44.71M
Dentsply International XRAY:US 145M 69M
Exact Sciences EXAS:US $ -182.95M 41.9M
Fluidigm FLDM:US $ -76.86M 66.62M
Henry Schein HSIC:US $ 239M 41.37M
IQVIA Holdings Inc IQV:US $ 606M 10M
Nanostring Technologies NSTG:US $ -39.42M 10.24M
Orasure Technologies OSUR:US $ -16.03M 7.1M
Pacific Biosciences Of California PACB:US $ -81.5M 13.34M
Peregrine Pharmaceuticals PPHM:US $ 0.59M 1.66M
Pfizer PFE:US $ 11328M 4083M
Repligen RGEN:US $ 66.75M 10.48M
Thermo Fisher Scientific TMO:US $ 3355M 760M
Waters WAT:US $ 200.12M 62.87M
West Pharmaceutical Services WST:US $ 189.1M 0.4M